Company Description
Prenetics Global Limited, a consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.
The company operates in three segments: Prevention, Diagnostics, and Consumer Health. It operates IM8 Health that sells health and wellness products; and provides fulfillment and distribution services for sports nutrition products under the Consumer Health segment.
The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions under Prevention segment.; and ACT Genomics that provides precision oncology testing services under the Diagnostics segment.
In addition, it develops and commercializes multi-cancer early detection technologies. Further, the company offers a range of genomic profiling panels tailored for requirements and clinician needs.
Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
| Country | Hong Kong |
| Founded | 2014 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 285 |
| CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 703-706, K11 Atelier King’s Road, 728 King’s Road Quarry Bay Hong Kong | |
| Phone | 852 2210 9588 |
| Website | prenetics.com |
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245106 |
| ISIN Number | KYG722451229 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Samantha Kwok | Chief of Staff to Group Chief Executive Officer and Vice President of People & Operations |
| Sheng Wu Yeung | Co-Founder, Chairperson and Chief Executive Officer |
| Dr. Chi Hung Tzang Ph.D. | Co-Founder and Chief Scientific Officer |
| Hoi Chun Lo | Chief Financial Officer |
| Dr. Senthil Kumar Sundaram M.D. | Chief Clinical Officer |
| Joel Neoh | Chief Consumer Officer |
| David Eric Vanderveen | Director and President of Americas |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 7, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Apr 30, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Mar 5, 2025 | 6-K | Report of foreign issuer |
| Dec 13, 2024 | 6-K | Report of foreign issuer |
| Nov 27, 2024 | 6-K | Report of foreign issuer |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | SCHEDULE 13G/A | Filing |
| Oct 15, 2024 | 6-K | Report of foreign issuer |
| Oct 7, 2024 | 6-K | Report of foreign issuer |
| Sep 27, 2024 | 6-K | Report of foreign issuer |